- Home
- ZKH vs INNV Comparison
ZKH vs INNV Comparison
Compare ZKH & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZKH | INNV |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.5M | 485.4M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZKH | INNV |
|---|---|---|
| Price | $3.22 | $5.77 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 250.1K | 186.5K |
| Earning Date | 11-20-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,236,195,501.00 | $884,662,000.00 |
| Revenue This Year | $2.44 | $11.18 |
| Revenue Next Year | $9.14 | $9.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.48 |
| 52 Week Low | $2.50 | $2.60 |
| 52 Week High | $3.90 | $6.26 |
Technical Indicators
Market Signals| Indicator | ZKH | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 53.94 | 56.33 |
| Support Level | $3.10 | $5.66 |
| Resistance Level | $3.31 | $6.10 |
| Average True Range (ATR) | 0.12 | 0.36 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 30.77 | 73.45 |
Price Performance
Historical ComparisonAbout ZKH ZKH Group Limited
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.